Additional Metadata
Persistent URL dx.doi.org/10.1093/annonc/mdw372.39, hdl.handle.net/1765/126459
Journal Annals of Oncology
Citation
Meisel, A, Vogt, D.R, de Wit, R, de Bono, J.S, Sartor, A.O, Eisenberger, M.A, & Stenner-Liewen, F. (2016). Neutropenia grade ≥ 3 during treatment with docetaxel (DOC) is associated with an improved overall survival (OS): A retrospective analysis of the TAX327 phase III trial. Annals of Oncology, 27. doi:10.1093/annonc/mdw372.39